Nagi Bioscience SA
EPFL Innovation Park – Building L
Replacing Animal Testing with Tests on Microorganisms
Testing of new substances is key to ensuring their efficacy and safety for humans and the environment. These tests are conducted on animals, which is ethically problematic, expensive and time-consuming.
EPFL spin-off Nagi Bioscience developed the first device that allows fully automated and standardized substance testing on the micro-organism C. elegans as a sustainable, ethical and cost-effective alternative to animal testing, while still providing whole-organism results.